NeoControl offers renewed hope to those patients whose only previous treatment options were surgery, drugs or behavioral therapies.

How does NeoControl therapy work?
Special electromagnets have been designed and built into the seat of the NeoControl chair. The effective magnetic field above the magnets is small - about the size of a small pineapple. When the patient is sitting the chair, the muscles of the pelvic floor are positioned directly above the magnetic field. By adjusting the strength of the field, the nerves and muscles of the pelvic floor are induced to contract. The rate and strength of the pelvic floor contractions can be adjusted to optimal settings using controls, like tuning the frequency and volume on a radio. 

The effect of this field on the pelvic floor muscles is completely natural. There is a scientific relationship between magnetic fields and electric current to induce activity in nerves and muscles; when muscles contract, it is the electric signals from the nerves that trigger the contraction and coordinate the activity. NeoControl induces these natural patterns of activity in nerves and muscles by using electromagnetic stimulation. In simplest terms, NeoControl is a personal trainer for your pelvic floor muscles; only it does all the exercise for you.

How does NeoControl cure incontinence?
For most urinary incontinence patients, leakage is caused by weakness in the muscles of the pelvic floor, either due to general atrophy with age, damage after giving birth, hysterectomy, radical prostatectomy, or a combination of these factors. When the pelvic floor muscles are made to exercise by stimulation, this activity will help to strengthen and restore effective control. Multicenter clinical studies have confirmed the benefits of electromagnetic stimulation of the pelvic floor for the treatment of incontinence.

What else can ExMI™ do?
In recent years, dozens of clinical studies in 15 countries have been implemented regarding future applications of this technology. The basics of this technology listed above, along with the fact that such muscle activity radically improves blood flow, indicate a variety of additional targets for this therapy. Many of the following conditions are pending FDA approval* for treatment with ExMI: fecal incontinence, prostatitis/prostadynia, interstitial cystitis, radical prostatectomy, benign prostatic hypertrophy (BPH), post-partum incontinence, female sexual dysfunction, male hormone and sperm count deficiency, pelvic pain in men and women, neuropathy due to chemotherapy/diabetes, and arthritis.

*Important Note: Neotonus, Inc stresses that the treatment for these conditions using NeoControl has not yet been approved in the United States. For more information about ongoing clinical studies and the NeoControl unit nearest you, send an inquiry here.